Prevalence of hypertension, pre-hypertension and undetected hypertension in Mashhad, Iran

Mediterranean Journal of Nutrition and Metabolism

Volumn 9, Issue 3, 2016, Pages 213-223

  Ebrahimi, Mahmoud ^a   Heidari Bakavoli, Ali Reza ^a   Mazidi, Mohsen ^d   Moohebati, Mohsen ^a,b   Azarpazhooh, Mahmoud Reza ^b   Nematy, Mohsen ^b   Tayyebi, Mohammad ^a   Safarian, Mohammad ^b   Esmaeili, Habib ^b   Parizadeh, Seyed Mohammad Reza ^b   Ghayour Mobarhan, Majid ^b   Ferns, Gordon A ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

^d INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Coronary heart disease; Hypertension; Pre hypertension

Indexed keywords

ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREHYPERTENSION; PREVALENCE; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 85011547126     PISSN: 1973798X     EISSN: 19737998     Source Type: Journal    
DOI: 10.3233/MNM-150046     Document Type: Article

References (35)

1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Bmj. 2009;338:b1665.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217-23.
3. World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002. http://www.who.int/whr/2002.
4. Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechere-Bertschi A. 1999–2009 trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One. 2012;7:e39877.
5. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611-9.
6. Ghayour-Mobarhan M, Moohebati M, Esmaily H, Ebrahimi M, Parizadeh SM, Heidari-Bakavoli AR, et al. Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: Design, baseline characteristics and 10-year cardiovascular risk estimation. Int J Public Health. 2015;60(5):561-72.
7. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835-8.
8. An epidemiological approach to describing risk associated with blood pressure levels. Final report of theWorking Group on Risk and High Blood Pressure. Hypertension. 1985;7:641-51.
9. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevelance of hypertension in Tehran adult population. Journal of Human Hypertension. 2002;16:305-12.
10. Lawes CM, Rodgers A, Bennet DA, Parag V, Suh I, Ueshima H. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2004;21(4):707-16.
11. Dobrin PB. Mechanical properties of arteries. Physiol Rev. 1978;58:397-449.
12. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-64
13. The Third National Health and Morbidity Survey. 2006. Abstracts: Hypertension and hypercholesteremia[Internet]. Available from: http://www.nih.gov.my./NHMS/abstracts18.html.
14. Rimm EB, Stampfer MJ, Giovannuci E. Body size and fat distribution as predictors of coronary heart disease among middle aged and older US men. Am J Epidemiol. 1995;141:1117-27.
15. World Health Organization. (2004) Cameroon Burden of Diabetes (CamBoD) Project: Baseline survey report, Geneva:World Health Organisation.
16. Harrison W, Marshall T. The epidemiology of blood pressure in East Asia. J Hum Hypertens. 2006;20:97-9.
17. Tsai AC, Liou JC, Chang MC. Interview to study the determinants of hypertension in older adults in Taiwan: A population based cross sectional survey. Asia Pac J Clin Nutr. 2007;16(2):338-45.
18. Walker R, Whiting D, Unwin N, Mugusi F, Swai M, Aris E. Stroke incidence in rural and urban Tanzania: A prospective, communitybased study. Lancet Neurology. 2010;9:786-92.
19. Poulter NR, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Rose G, et al. The Kenyan Luo igration study: Observations on the initiation of a rise in blood pressure. BMJ. 1990;300:967-72.
20. Grassi G, Seravalle G, Cattaneo BM, Bolla G, Lafranchi A, Colombo M, et al. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560-3.
21. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 1989;2:1255-325.
22. Rocchini AP, Yang IQ, Gokee A. Hypertension and insulin resistance are not directly related in obese dogs. Hypertension. 2004;43:1011-6.
23. Malaza A, Mossong J, Barnighausen T, Newell ML. Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS ONE. 2012;7:e47761.
24. Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012;60:653-8.
25. Tringler M, Rodriguez EM, Aguera D, Molina JD, Canziani GA, Diaz A. High blood pressure, overweight and obesity among rural scholars from the vela project: A population-based study from South America. High Blood Press Cardiovasc Prev. 2012;19:41 6. 23.
26. Hou DQ, Cheng H, Wang TY, Wang L, Zhao D, Zhang MM, et al. Study on the relationship of blood pressure with BMI,FMP and waist circumference among children and adolescents in Beijing. Chinese Journal of Practical Pediatrics. 2010;25(7):4.
27. Ribeiro JC, Guerra S, Oliveira J, Teixeira-Pinto A, Twisk JW, Duarte JA, et al. Physical activity and biological risk factors clustering in pediatric population. Prev Med. 2004;39:596-601.
28. ER Miller III, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, et al. “Results of the diet, exercise, and weight loss intervention trial (DEWIT),” Hypertension. 2002;40(5):612-8.
29. Hermansen K. “Diet, blood pressure and hypertension,” British Journal of Nutrition. 2000;83(1):S113-9.
30. Jonas MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals: AHA Medical/ Scientific Statement. Circulation. 1992;86:1664-9.
31. Kannel WB. Importance of hypertension as a risk factor in cardiovascular disease. In: Hypertension: Pathopsychology and Treatment. New York, NY: McGraw-Hill. 1977, 888-910.
32. Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: An overview of molecular mechanisms. Curr Vasc Pharmacol. 2007;5:276-92.
33. Tuomilehto J, Elo J, Nissmen A. Smoking among patients with malignant hypertension. BMJ. 1982;1:1086.
34. Cappell CL, Herrmann J, McGee N, Rosenfeld D. The quality of life in the Chicago Collar counties: Work, family, and well-being. The Annual Meetings of the Midwest Sociological Society, St. Louis: April 6, 2001.
35. Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino RB, Benjamin EJ. Marital status, marital strain and risk of coronary heart disease or total mortality: The Framingham off spring study. Psychosom Med. 2007;69:509-13.